Bondent Secures Hundreds of Millions in Series D Funding Led by Legend Capital, Qiming Venture Partners, and Xiamen C&D
VCBeat (WeChat ID: vcbeat) learned that on August 2, 2019, Shanghai Bondent Technology Co., Ltd. announced the completion of its Series D financing round, with Legend Capital, Qiming Venture Partners, and Xiamen C&D Corporation as the investors. Previously, Bondent had received investments from IDG Capital, Green Spring Ventures, Qiming Venture Partners, Sunshine Property & Casualty Insurance, Shanghai Health Industry Fund, and Noah Holdings.
Shanghai Bondent Technology Co., Ltd. was established in 2009 as a platform company providing “integrated” services to dental healthcare institutions. From physician education and training, and the introduction of advanced foreign technologies, to independent domestic R&D and manufacturing, the company is committed to building a new, healthy dental healthcare ecosystem through an “industry + internet” model. It aims to elevate China’s dental healthcare technology and industrial standards, empower dentists to achieve success, and safeguard the oral health of 1.3 billion Chinese people.
Meanwhile, Bondent has continuously introduced advanced international products and technologies, promoting the popularization and development of techniques such as microscopic root canal therapy and periodontal implantology in China. Committed to fostering domestic industry, Bondent strives to make Chinese brands more accessible to the general public and to win global appreciation for Made-in-China products.
Bondent Group currently has eight subsidiaries, with nearly 1,000 employees across China. It achieves annual growth exceeding 50% and serves dentists and clinics in more than 40 countries worldwide.
Tian Fangjun, Chairman of Bondent, stated: “Bondent began its journey by distributing advanced international products and providing technical training. Over the past decade, we have transitioned to independent research, development, and manufacturing, remaining committed to elevating the standards of dental medical technology and industry in China. We strive to provide cost-effective products and services to healthcare institutions, empowering dentists and dental practices in their operations. Bondent is dedicated to bringing digital technologies, precision diagnosis and treatment, and comfortable patient experiences to every clinic and patient. Through our digital platform, we support dentists in establishing their practices and safeguard patients’ oral health. With this round of financing, Bondent will continue to increase investment in R&D and expand into international markets, aiming to establish Chinese domestic dental brands on the global stage.”
Wang Jianfei, Managing Director at Legend Capital, stated: “The healthcare sector has always been a key focus and investment area for Legend Capital. Dentistry is one of the fastest-growing segments within the healthcare industry. Shanghai Bondent Technology Co., Ltd. (Bondent) has deeply cultivated the dental field, possessing unique advantages in industrial layout, product technology, and market presence. After ten years of development, several of its products have achieved the number one market share in China. Its international market expansion has proceeded smoothly, while the introduction of advanced international technologies and collaborations have driven product upgrades and promoted industry development. Legend Capital hopes to jointly promote the growth of the dental industry through strategic cooperation with Bondent.”
Related Reading: